新型冠狀病毒

Fosun and BioNTech launch $135m vaccine hunt for coronavirus

The race to produce a coronavirus vaccine accelerated on Monday when the German group BioNTech announced a $135m partnership with Fosun Pharma of China to develop a Covid-19 vaccine, which it said could begin clinical testing in late April.

Fosun will make a $50m equity investment in BioNTech and pay the Mainz-based company a further $85m in vaccine development and commercialisation fees. 

The move came as more than 20 companies and public laboratories worldwide are already trying to develop a vaccine against the novel coronavirus as global anxiety about its spread continues to soar.

您已閱讀19%(588字),剩餘81%(2527字)包含更多重要資訊,訂閱以繼續探索完整內容,並享受更多專屬服務。
版權聲明:本文版權歸FT中文網所有,未經允許任何單位或個人不得轉載,複製或以任何其他方式使用本文全部或部分,侵權必究。
設置字型大小×
最小
較小
默認
較大
最大
分享×